Abstract
There has been renewed interest in the demarcation of pediatric catatonia from other pediatric conditions including autism. An update on symptoms, prevalence, evaluation, treatment, risk factors, and experimental models of pediatric catatonia is presented. Recent prevalence rates of pediatric catatonia vary widely across studies, suggesting that catatonia may not be rare in younger patients. Symptoms and diagnostic criteria for pediatric catatonia are the same as in adults. Studies and clinical experience support benzodiazepines and electroconvulsive therapy, including maintenance electroconvulsive therapy, as treatment options. Sometimes catatonia develops after severe psychological trauma. Historical and contemporary clinical and experimental catatonia models are available for future research, focusing on motor circuitry dysfunction, abnormal neurotransmitters, epileptic discharges, genetics, neuroendocrine and immune abnormalities, fear reactions akin to the animal defense strategy of tonic immobility, and developmental risk factors. There have been advances in demarcating pediatric catatonia in a wide variety of patients as a treatable condition that requires prompt identificiation. A model of developmental impairment complements clinical and experimental catatonia models.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 120-129 |
| Number of pages | 10 |
| Journal | Current Psychiatry Reviews |
| Volume | 9 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2013 |
Fingerprint
Keywords
- Adolescents
- Benzodiazepines
- Catatonia
- Children
- Electroconvulsive therapy
- Models
- Pediatric
- Treatment
ASJC Scopus subject areas
- Psychiatry and Mental health
Cite this
Pediatric catatonia : Updating an old syndrome in young people. / Dhossche, Dirk; Wachtel, Lee Elizabeth; Shorter, Edward; Ghaziuddin, Neera.
In: Current Psychiatry Reviews, Vol. 9, No. 2, 2013, p. 120-129.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pediatric catatonia
T2 - Updating an old syndrome in young people
AU - Dhossche, Dirk
AU - Wachtel, Lee Elizabeth
AU - Shorter, Edward
AU - Ghaziuddin, Neera
PY - 2013
Y1 - 2013
N2 - There has been renewed interest in the demarcation of pediatric catatonia from other pediatric conditions including autism. An update on symptoms, prevalence, evaluation, treatment, risk factors, and experimental models of pediatric catatonia is presented. Recent prevalence rates of pediatric catatonia vary widely across studies, suggesting that catatonia may not be rare in younger patients. Symptoms and diagnostic criteria for pediatric catatonia are the same as in adults. Studies and clinical experience support benzodiazepines and electroconvulsive therapy, including maintenance electroconvulsive therapy, as treatment options. Sometimes catatonia develops after severe psychological trauma. Historical and contemporary clinical and experimental catatonia models are available for future research, focusing on motor circuitry dysfunction, abnormal neurotransmitters, epileptic discharges, genetics, neuroendocrine and immune abnormalities, fear reactions akin to the animal defense strategy of tonic immobility, and developmental risk factors. There have been advances in demarcating pediatric catatonia in a wide variety of patients as a treatable condition that requires prompt identificiation. A model of developmental impairment complements clinical and experimental catatonia models.
AB - There has been renewed interest in the demarcation of pediatric catatonia from other pediatric conditions including autism. An update on symptoms, prevalence, evaluation, treatment, risk factors, and experimental models of pediatric catatonia is presented. Recent prevalence rates of pediatric catatonia vary widely across studies, suggesting that catatonia may not be rare in younger patients. Symptoms and diagnostic criteria for pediatric catatonia are the same as in adults. Studies and clinical experience support benzodiazepines and electroconvulsive therapy, including maintenance electroconvulsive therapy, as treatment options. Sometimes catatonia develops after severe psychological trauma. Historical and contemporary clinical and experimental catatonia models are available for future research, focusing on motor circuitry dysfunction, abnormal neurotransmitters, epileptic discharges, genetics, neuroendocrine and immune abnormalities, fear reactions akin to the animal defense strategy of tonic immobility, and developmental risk factors. There have been advances in demarcating pediatric catatonia in a wide variety of patients as a treatable condition that requires prompt identificiation. A model of developmental impairment complements clinical and experimental catatonia models.
KW - Adolescents
KW - Benzodiazepines
KW - Catatonia
KW - Children
KW - Electroconvulsive therapy
KW - Models
KW - Pediatric
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=84878667989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84878667989&partnerID=8YFLogxK
U2 - 10.2174/1573400511309020006
DO - 10.2174/1573400511309020006
M3 - Article
VL - 9
SP - 120
EP - 129
JO - Current Psychiatry Reviews
JF - Current Psychiatry Reviews
SN - 1573-4005
IS - 2
ER -